Daytime sleepiness, sleep quality, hallucinations, and sleep paralysis in patients with narcolepsy: Results from the REST-ON trial, a pivotal phase 3 study of ft218, a once-nightly sodium oxybate formulation

Authors
Category Primary study
JournalNeurology
Year 2021
This article has no abstract
Epistemonikos ID: 7a034c2eefe54861d273fb18a0351b0038b0ec68
First added on: Feb 13, 2025